Form 4 for SIBN SI-BONE, Inc.
Accepted 2026-08-21 17:56:27 ET · period of report 2026-08-19 · accession 0001853089-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-08-21 17:56 | 2026-08-19+ | SIBN | Maheshwari Anshul | Chief Op, Financial Off | S - Sale | $19.86 | -17.0K | 234.9K | -7% | -$337.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-19 | S | D | 5,747 | $19.55 | 246,148 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025. (F2) The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.50 to $19.67, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. |
| 2 | Common | Common Stock | 2026-08-21 | S | D | 11,228 | $20.02 | 234,920 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025. (F3) The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.05, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. (F4) Includes 167,604 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. |